CIDRAP newsletters options
(CIDRAP News) A US Food and Drug Administration (FDA) panel yesterday recommended that the agency approve a smallpox vaccine made by British biotechnology company Acambis plc that is currently being stockpiled for the US government.
(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) today released a detailed report about a 2-year-old Indiana boy who is recovering from a severe eczema vaccinatum infection contracted through contact with his father, a soldier who had recently received a smallpox vaccine.
Business continuity planners say they're talking to their employees and other stakeholders about pandemic preparedness. Is it really happening?
Less than 2 years ago, H5N1 seized the headlines.
(CIDRAP News) A US Food and Drug Administration (FDA) advisory panel unanimously agreed Wednesday that FluMist, a nasal spray vaccine against seasonal flu, is safe and effective in children 2 years of age and older.
Second in a two-part series examining the numbers and epidemiologic factors surrounding the virus that many experts believe could lead to the next pandemic. Part 1 explored why the apparently lower number of human H5N1 cases in early 2007 does not mean the pandemic threat is receding.
(CIDRAP News) At first glance, the Web page looks like an overhead shot of a fantastic game board: a mapidentifiably Los Angelessprinkled with faceted roundels in a half-dozen colors.
(CIDRAP News) The World Health Organization (WHO) today recognized 15 H5N1 avian influenza cases from Indonesia dating back to late January, a few weeks after the country stopped sending H5N1 virus samples to the WHO as a protest against developing nations' lack of equal access to pandemic vaccines.
(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists (CSTE) today released a 3-day online course to teach state and local public health officials how to respond to human cases of H5N1 avian influenza.
(CIDRAP News) Indonesia's health minister announced today at the World Health Organization's (WHO's) annual meeting that the country has resumed sending H5N1 avian influenza virus samples to the WHO, appearing to end a 5-month standoff over developing countries' access to vaccines.
(CIDRAP News) Indonesia's health ministry reported today that a 26-year-old pregnant woman who died 2 days ago tested positive for H5N1 avian flu, making her the country's second fatality in as many weeks.
The woman, who was 4 months pregnant, died at a hospital in Medan in North Sumatra, a health ministry official identified as Joko told Agence France Presse (AFP).
(CIDRAP News) The dispute over the sharing of H5N1 avian influenza samples was high on the agenda as the annual meeting of World Health Organization (WHO) member countries began today in Geneva.
(CIDRAP News) – The city of Edmonton, Alta., recently announced that it was stockpiling an herbal supplement in the hope of boosting the immunity of police, firefighters, and other essential workers during an influenza pandemic.
By buying a ginseng product from CV Technologies, Inc., a company based in Edmonton, the city has become the first in North America to add an herbal supplement to its pandemic stockpile, according to media reports.
(CIDRAP News) Resistance to oseltamivir (Tamiflu) over the three influenza seasons from 2003 to 2006 remained low in Japan, the country with the world's highest use of the drug, according to a preliminary study from the World Health Organization (WHO).
First in a two-part series examining the numbers and epidemiologic factors surrounding the virus many experts believe could lead to the next pandemicand what they mean for your business.
Ask people which private sector most needs to be prepared for a pandemic, and I bet they will tell you healthcare. Such a conclusion is understandable given the grim vision of a pandemic with its untold numbers of severely sick and dying people in communities all across the world.
If only it could be that simple.
(CIDRAP News) The World Health Organization (WHO) said yesterday that "a number" of human vaccines against the H5N1 avian influenza may become available soon, but declined to say whether they should be used before a flu pandemic arises.
(CIDRAP News) The European Union (EU) this week approved a "mock-up" influenza vaccine made by Novartis to permit a faster start on vaccine production in the event of a flu pandemic.
(CIDRAP News) The US Food and Drug Administration (FDA) yesterday cleared the way for two N-95 respirator models to be marketed as devices that can reduce a user's risk of becoming ill during an influenza pandemic or other public health emergency.
(CIDRAP News) A recent survey sponsored by the American Public Health Association (APHA) indicates that about a third of Americans have made no preparations for a public health emergency and nearly 90% have prepared less than they think they should.
